Detalles de la búsqueda
1.
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.
Clin Exp Immunol
; 202(3): 353-362, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32757277
2.
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting.
Cancer Rep (Hoboken)
; : e1966, 2023 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38148576
Resultados
1 -
2
de 2
1
Próxima >
>>